公司資料
IGC Pharma, Inc. 股價、新聞與催化劑
- 股票代碼:
- IGC
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.28 USD (-5.98%)
收盤價
最後更新: 2026年8月17日
29M USD
市值
股價為何變動
As of Aug 17, 2026, IGC closed down 5.98% at $0.2800. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
IGC Pharma is a biopharmaceutical company exploring cannabinoid-based and other therapeutic programs, including neuropsychiatric and metabolic concepts. Its identity has been tied to a broad but still early-stage development story.
所在地與產業分類
IGC Pharma is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotech with a neuropsychiatry and cannabinoid angle.
商業模式特徵
The company depends on early development work, regulatory pathfinding, and capital efficiency. Investors typically watch program updates, preclinical or early clinical signals, and whether the company can sharpen its focus.
生技產業定位
IGC occupies a speculative small-cap biotechnology niche. It is more of an early-stage concept story than a mature clinical platform.
未來催化劑
- IGC Pharma’s catalysts are its cannabis-derived and neuro-related programs, plus any operating update that clarifies commercial progress. The market will care about whether the company can turn the platform into a real business.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。